Prosecution Insights
Last updated: August 18, 2026

Examiner: REILLY, SOPHIA JANE

Tech Center 1600 • Art Units: 1627 1629

This examiner grants 61% of resolved cases

Performance Statistics

60.6%
Allow Rate
+0.6% vs TC avg
96
Total Applications
+49.1%
Interview Lift
1234
Avg Prosecution Days
Based on 66 resolved cases, 2023–2026

Rejection Statute Breakdown

2.8%
§101 Eligibility
17.7%
§102 Novelty
32.9%
§103 Obviousness
25.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18285812 GPR119 AGONISTS Non-Final OA Kallyope, Inc.
18720571 COVALENTLY BINDING INHIBITORS OF G12S, G12D AND/OR G12E MUTANTS OF K-RAS GTPASE Non-Final OA The Regents of the University of California
19257262 PI4-Kinase Inhibitors and Methods of Using the Same Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18800559 COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK Non-Final OA Novartis AG
18730214 IMMUNOMODULATORY LIPIDS AND USES THEREOF Non-Final OA The General Hospital Corporation
18802257 PROCESSES FOR THE PREPARATION OF 1,2,3,5,6,7-HEXAHYDRO-S-INDACENE DERIVATAIVES Non-Final OA Hoffmann-La Roche Inc.
18068407 AMIDOPYRIMIDONE DERIVATIVES Non-Final OA Hoffmann-La Roche Inc.
18800769 SULFONATO RESORCINARENE-COMPLEXED FLUOROQUINOLONES AND METHODS OF USE Non-Final OA University of Cincinnati
18778440 DIAGNOSIS OF IMMUNITY REDUCTION THROUGH INTESTINAL MICROFLORA ANALYSIS OF STOMACH CANCER PATIENTS, AND THERAGNOSTIC COMPOSITION USING INTESTINAL MICROFLORA Non-Final OA THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
17919726 COMBINATION THERAPY OF ARTEMISININ-RELATED COMPOUNDS AND HISTONE DEACETYLASE INHIBITORS FOR TREATMENT OF HPV-RELATED BENIGN, PREMALIGNANT, AND MALIGNANT DISEASES Final Rejection Georgetown University
18742267 COMPOSITIONS AND METHODS RELATING TO USE OF PHOSPHATIDIC ACID TO RESCUE FETAL ALCOHOL SPECTRUM DISORDER (FASD) GROWTH RESTRICTION AND BLOOD VESSEL CONSTRICTION Non-Final OA Wayne State University
18725842 Use of L-cysteine for improving the structure and function of gastric mucosa Non-Final OA Biohit Oyj

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month